MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-10-0017010
Altmann Pharmaceuticals Private Limited
Altmann Pharmaceuticals Private Limited - pharma in Karnal, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹11.17 Lakh
▲ 30% YoY
Net profit · FY 2025
₹612
Net margin 0.1%
EBITDA · FY 2025
₹16,226
EBITDA margin 1.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Altmann Pharmaceuticals Private Limited
Data last updated:
Altmann Pharmaceuticals Private Limited is a private limited company based in Karnal, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 July 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24303HR2013PTC049891. Its GSTIN is 06AALCA8344F1ZM (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Komal Jeet and Neha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 217 Bank Colony Near Bank Colony Park Rajiv Puram, Karnal, Haryana, India – 132001.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.17 Lakh, a growth of 30% compared to the previous year. For the same year it recorded a net profit of ₹612 (net margin 0.1%) and EBITDA of ₹16,226 (EBITDA margin 1.5%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 3% over five years.
Altmann Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-10-0017010). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24303HR2013PTC049891
Registration Number 049891
Incorporation Date 22 July 2013
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-HR-10-0017010
Key People
Komal Jeet Director Neha Director Recognitions & Rankings of Altmann Pharmaceuticals
Contact details
Altmann Pharmaceuticals Private Limited's registered office is in Karnal, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address217 Bank Colony Near Bank Colony Park Rajiv Puram, Karnal, Haryana, India – 132001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Altmann Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Altmann Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Altmann Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Altmann Pharmaceuticals Private Limited, buy the company report.
Financials of Altmann Pharmaceuticals Private Limited
FY 2025 filings availableAltmann Pharmaceuticals Private Limited reported revenue of ₹11.17 Lakh (up 30% YoY) for FY 2025.
Revenue · FY 2025
₹11.17 Lakh ▲ 30%
Net profit · FY 2025
₹612 margin 0.1%
EBITDA · FY 2025
₹16,226 margin 1.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 30%
3 years · compounded
▲ 2%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▲ 65%
3 years · compounded
▲ 2%
5 years · compounded
▲ 4%
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 30% growth in the latest year. EBITDA rose 65% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16,226 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹612 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Altmann Pharmaceuticals Private Limited, buy the company report.
Board of directors of Altmann Pharmaceuticals Private Limited
Altmann Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Komal Jeet | Director | 22 Jul 2013 | 13 Years 3 Months | Current |
| Neha | Director | 30 Jan 2017 | 9 Years 9 Months | Current |
Peer comparison
Altmann Pharmaceuticals Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Brugen Pharmaceuticals Private Limited | ₹11.23 Lakh (FY 2025) | 88.0% | Jabalpur, Madhya Pradesh, India | |||
| Panmed Pharmaceuticals Private Limited | ₹11.21 Lakh (FY 2017) | -49.0% | Chennai, Tamil Nadu, India | |||
| Rynn Pharmaceuticals Private Limited | ₹11.21 Lakh (FY 2024) | -39.0% | Ghaziabad, Uttar Pradesh, India | |||
| Fronde Pharmaceuticals Private Limited | ₹11.2 Lakh (FY 2025) | -8.0% | Cuttack, Odisha, India | |||
| Sagar & Kaka Pharmacy Private Limited | ₹11.18 Lakh (FY 2022) | 1039.0% | Kashipur, Uttarakhand, India | |||
| Altmann Pharmaceuticals Private Limitedthis company | ₹11.17 Lakh (FY 2025) | ₹612 | 0.1% | 30.0% | Karnal, Haryana, India | |
| Aak Business Private Limited | ₹11.17 Lakh (FY 2025) | 27.0% | Gorakhpur, Uttar Pradesh, India | |||
| Specura Pharmaceuticals Private Limited | ₹11.16 Lakh (FY 2025) | 48.0% | Pune, Maharashtra, India | |||
| Lifecord Pharmaceuticals Private Limited | ₹11.16 Lakh (FY 2019) | 132.0% | Ghaziabad, Uttar Pradesh, India | |||
| Lion in Pharmaceuticals India Private Limited | ₹11.13 Lakh (FY 2025) | -22.0% | Yelahanka, Karnataka, India |
To see the full peer comparison of Altmann Pharmaceuticals Private Limited, buy the company report.
Auditor
Altmann Pharmaceuticals Private Limited is audited by KAKKAR & TUTEJA for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KAKKAR & TUTEJA | FY 2017 | 019953N |
Shareholding
The shareholding of Altmann Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Altmann Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Altmann Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Altmann Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Altmann Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AALCA8344F1ZM | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Altmann Pharmaceuticals Private Limited, buy the company report.
Recent activity
Altmann Pharmaceuticals Private Limited has 4 board changes on record since 2013: 3 appointments and 1 cessation. The latest: Charanjit Arora ceased to be Director on 30 Jan 2017.
AGM
Altmann Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Altmann Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Charanjit Arora ceased to be Director.
Appointed
Neha was appointed as Director.
Appointed
Charanjit Arora was appointed as Director.
Appointed
Komal Jeet was appointed as Director.
Incorporation
22 Jul 2013
Altmann Pharmaceuticals Private Limited was registered on 22 Jul 2013 with Roc Delhi & aged 13 years 3 months as per MCA records.
Frequently asked questions
Altmann Pharmaceuticals is an active private limited company based in Karnal, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 July 2013 (13+ years old) and is registered under CIN U24303HR2013PTC049891.
Altmann Pharmaceuticals has 2 current directors:
- Komal Jeet - Director
- Neha - Director
The latest financial statements of Altmann Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Altmann Pharmaceuticals is 06AALCA8344F1ZM, registered in Haryana.
The CIN (Corporate Identification Number) of Altmann Pharmaceuticals is U24303HR2013PTC049891. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Altmann Pharmaceuticals was incorporated on 22 July 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Altmann Pharmaceuticals by revenue are Brugen Pharmaceuticals Private Limited, Panmed Pharmaceuticals Private Limited, Rynn Pharmaceuticals Private Limited, Fronde Pharmaceuticals Private Limited, Sagar & Kaka Pharmacy Private Limited and 4 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Charanjit Arora ceased to be Director on 30 Jan 2017. Neha was appointed as Director on 30 Jan 2017. Charanjit Arora was appointed as Director on 22 Jul 2013. Altmann Pharmaceuticals has 4 board changes on record in total.
Yes, Altmann Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-10-0017010).
The registered office of Altmann Pharmaceuticals is at 217 Bank Colony Near Bank Colony Park Rajiv Puram, Karnal, Haryana, India – 132001.
Altmann Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages